Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report

CONCLUSION: The potential risk of developing autoimmune liver diseases after DAA treatment should be considered.PMID:38495284 | PMC:PMC10941733 | DOI:10.4254/wjh.v16.i2.286

Source: World Journal of Hepatology - March 18, 2024 Category: Gastroenterology Authors: Yoshiki Morihisa Hobyung Chung Shuichiro Towatari Daisuke Yamashita Tetsuro Inokuma Source Type: research